Duarte-Raya F, Granados-Ramírez MP

Language: Spanish
References: 13
Page: 141-146
PDF size: 47.36 Kb.

ABSTRACT

Background: the possibility of nosocomial infection is determined by factors relating to the patient, the presence and degree of immunodeficiency, and interventions that become stronger the risk. A nosocomial outbreak is the emergence of an unusual case of a specific disease and is due to an infectious agent only. Our objective was to analyze the risk of Burkholderia cepacia with a risk stratification criterion in a pediatric intensive care unit (ICU).
Methods: an epidemiological outbreak, transverse, retrospective study was done. We included 71 patients from a pediatric ICU. Attack rate and fatality rate was obtained. We applied Fisher exact test with a level of significance p ‹ 0.05.
Results: regardless the risk stratification the Burkholderia cepacia infection showed no significant difference. The attack rate was 23.94, and the fatality rate in infected patient was 29.41. Candida albicans coinfection was present in 50 % of the cases; other kind of bacteria infection in 50 %was also seen. Therefore the treatment was the combination of different antimicrobials.
Conclusions: the paediatric intensive care patient is exposed to nosocomial infection including Burkholderia cepacia independent of its risk rating. Attachment and the monitoring of standard precautions with isolation strategy is suggested as a good preventive measure.

REFERENCES

1. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia in patients with cystic fibrosis in Canada: geographical distribution and clustering of strains. Emerg Infect Dis 2002;8:181-187.

2. Devine DA, Walling S, Morgan MM, Ashcroft AE, Bonass WA, Keen JN, et al. Interactions between antimicrobial peptides and polymyxin B sensitive burkholderia cepacia mutants in relation to lipopolysaccharide structure. Abstr Intersci Conf Agents Chemother Intersci Conf Antimicrob Agents Chemother 2003;14-17(43):abstract no. C1-1812.

3. Prilassning M, Daxboeck F, Wenisch C. Use of random amplified polymorphic DNA PCR for strain comparison of clinical obtained Stenotrophomonas maltophilia cultures. Int J Infect Dis 2004;216.

4. Bevivino A, Dalmastri C, Tabacchioni S,Chiarini L, Belli ML, Piana S, et al. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 2002;40 (3):846-851.

5. Cardoso-Hernández G, De Colsa-Ranero A, Zepeda- Orozco G, Arzate-Barbosa P, González-Saldaña N. Manifestaciones clínicas y factores de riesgo para bacteriemia por Burkholderia cepacia en niños. Rev Enfer Infec Pediatr 2007;20(80):92-98.

6. Secretaría de Salud. Norma Oficial Mexicana NOM-045- SSA2-2005, para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales. México: Diario Oficial de la Federación, 20 de noviembre de 2009.

7. Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein R. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003;37(1):59-64.

8. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzes risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001;32(7):1055-1061.

9. Bantar C, Sartori B, Vesco E, Heft C, Saúl M, Salamone, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practices, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003;37(2):180-186.

10. Secretaría de Salud. Norma Oficial Mexicana NOM-017- SSA2-1994, para la vigilancia epidemiológica. México: Diario Oficial de la Federación, 11 de octubre de 1999.

11. Fajardo-Olivares M. Cordero-Carrasco JL, Beteta-López A, Escobar-Izquierdo AB, Sacristán-Enciso B. Faringitis por Burkholderia cepacia. Transmisión de persona a persona. An Pediatr 2004;60(6):581-582.

12. Frías-Salcedo JA. Burkholderia cepacia (B. cepacia). Nuevo patógeno de infecciones nosocomiales. Serie de casos clínicos. Enf Inf Microbiol 2008 28(1):19-23.

13. González-Saldaña N, Hernández-Orozco H, Castañeda- Narváez JL, Barbosa-Arzate P, Lombardo-Aburto E, Girón- Hernández JA. Brotes de Burkholderia cepacia en el Instituto Nacional de Pediatría. Acta Pediatr Mex 2008;29(4):185- 188.